|
⚲
|
| Keyboard |
| Transdel Pharmaceuticals Inc | |
|---|---|
| Ticker | HROW |
| CIK # | 0001360214 |
| CUSIP | 415858109 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 4225 Executive Square Suite 485, La Jolla, CA 92037 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Harrow Health Inc | 2021-05-14 | 10.7 M | Exemption: 506(b) · Duration: One year or less · Revenue: $25,000,001 - $100,000,000 |
| Imprimis Pharmaceuticals Inc | 2016-12-30 | 10.1 M | Exemption: 506(b) · Duration: One year or less · Commission: $755,155 · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001360214] | 10-K | |
| [0001360214] | 10-Q | |
| [0001360214] | 3 | |
| [0001360214] | 4 | |
| [0001360214] | 5 | |
| [0001360214] | 8-K | |
| [0001360214] | D | |
| [0001360214] | SC 13D | |
| [0001360214] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Opaleye Management Inc
Common Stock, par value $0.001 per share
|
2026-03-04 | Sell | 4,263 | $39.67 | 169,113 |
|
Opaleye Management Inc
Common Stock, par value $0.001 per share
|
2026-03-04 | Sell | 134,000 | $39.67 | 5,315,780 |
|
Opaleye Management Inc
Common Stock, par value $0.001 per share
|
2026-03-03 | Sell | 59,000 | $39.15 | 2,309,850 |
|
Opaleye Management Inc
Common Stock, par value $0.001 per share
|
2026-03-03 | Sell | 1,309 | $39.15 | 51,247 |
|
Opaleye Management Inc
Common Stock, par value $0.001 per share
|
2026-02-27 | Sell | 5,000 | $54.18 | 270,900 |
|
Sullivan Patrick William
RSU · derivative
|
2026-01-30 | Grant | 15,000 | $0.00 | |
|
Sullivan Patrick William
RSU · derivative
|
2026-01-30 | Grant | 25,000 | $0.00 | |
|
Opaleye Management Inc
Common Stock, par value $0.001 per share
|
2026-01-06 | Sell | 20,000 | $53.35 | 1,067,000 |
|
BAUM Mark L
Common Stock
|
2025-12-12 | Tax withheld | 79,994 | $47.06 | 3,764,518 |
|
BOLL Andrew R
Common Stock
|
2025-12-12 | Option exercise | 60,000 | $3.95 | 237,000 |
|
BAUM Mark L
Common Stock
|
2025-12-12 | Option exercise | 180,000 | $3.95 | 711,000 |
|
BOLL Andrew R
Stock Option (Right to Buy) · derivative
|
2025-12-12 | Option exercise | 60,000 | $0.00 | |
|
BOLL Andrew R
Common Stock
|
2025-12-12 | Tax withheld | 26,665 | $47.06 | 1,254,855 |
|
BAUM Mark L
Stock Option (Right to Buy) · derivative
|
2025-12-12 | Option exercise | 180,000 | $0.00 | |
|
Stock Option (Right to Buy) · derivative
|
2025-09-01 | Grant | 30,000 | $0.00 | |
|
BAUM Mark L
Common stock
|
2025-07-21 | Option exercise | 600,000 | $7.87 | 4,722,000 |
|
BAUM Mark L
Common stock
|
2025-07-21 | Tax withheld | 313,338 | $37.08 | 11,618,573 |
|
BOLL Andrew R
RSU · derivative
|
2025-07-01 | Grant | 405,750 | $0.00 | |
|
BAUM Mark L
RSU · derivative
|
2025-07-01 | Grant | 889,500 | $0.00 | |
|
Silvernail Lauren P
RSU · derivative
|
2025-06-20 | Grant | 7,339 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 220 | 23,058,727 |
| 2025-12-31 | 216 | 24,357,290 |
| 2025-09-30 | 200 | 22,783,072 |
| 2025-06-30 | 161 | 21,846,767 |
| 2025-03-31 | 160 | 22,066,652 |
| 2024-12-31 | 172 | 22,705,371 |
| 2024-09-30 | 164 | 22,729,921 |
| 2024-06-30 | 112 | 20,471,152 |
| 2024-03-31 | 114 | 23,226,712 |
| 2023-12-31 | 113 | 24,666,427 |
| 2023-09-30 | 129 | 25,404,840 |
| 2023-06-30 | 113 | 23,363,353 |